US Patent 8039009 | US Patents | Expiry | Expiration | Dates

U.S.A

MEMANTINE HYDROCHLORIDE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8039009

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2029-03-24

Patent Use Code

U-539

Delist Requested

Application Number

22525

Patent Use Description

TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE

Product Number

4

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

MEMANTINE HYDROCHLORIDE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8039009

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2029-03-24

Patent Use Code

U-539

Delist Requested

Application Number

22525

Patent Use Description

TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE

Product Number

3

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8039009

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2029-03-24

Patent Use Code

U-1641

Delist Requested

Application Number

206439

Patent Use Description

MEMANTINE HCL/DONEPEZIL HCL COMBINATION FOR THE TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

MEMANTINE HYDROCHLORIDE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8039009

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2029-03-24

Patent Use Code

U-539

Delist Requested

Application Number

22525

Patent Use Description

TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

MEMANTINE HYDROCHLORIDE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8039009

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2029-03-24

Patent Use Code

U-539

Delist Requested

Application Number

22525

Patent Use Description

TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8039009

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2029-03-24

Patent Use Code

U-1641

Delist Requested

Application Number

206439

Patent Use Description

MEMANTINE HCL/DONEPEZIL HCL COMBINATION FOR THE TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE

Product Number

3

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8039009

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2029-03-24

Patent Use Code

U-1641

Delist Requested

Application Number

206439

Patent Use Description

MEMANTINE HCL/DONEPEZIL HCL COMBINATION FOR THE TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE